Search for: "Pfizer, Inc. v. Lee"
Results 1 - 20
of 53
Sorted by Relevance
|
Sort by Date
15 Feb 2016, 9:59 pm
By Donald Zuhn -- Last month, in Pfizer, Inc. v. [read post]
28 Jan 2016, 9:02 am
Patent Term Adjustment (PTA) is utilized by the Patent Office so that an inventor’s patent protection is not limited by delays caused by the Patent Office. [read post]
23 Feb 2016, 7:48 am
” Pfizer v. [read post]
19 Oct 2011, 5:00 am
(Pfizer Inc. v. [read post]
6 Feb 2012, 10:19 am
Pfizer, Inc., cause no. 1222-CC00766, was filed on Feb. 2 in St. [read post]
25 Jan 2010, 5:00 am
Pfizer, Inc., 2010 WL 163583, slip op. [read post]
5 Sep 2007, 4:58 am
Litig., 414 F.Supp.2d 398, 401-02 (S.D.N.Y.2006); see In re Pfizer Inc. [read post]
5 Sep 2007, 12:56 am
Litig., 414 F.Supp.2d 398, 401-02 (S.D.N.Y.2006); see In re Pfizer Inc. [read post]
21 Jun 2012, 10:40 am
In re Pfizer Inc. [read post]
27 Jan 2012, 11:20 am
Gerstner Jr. 1993-2002 $189,005,929 Pfizer Inc. [read post]
9 Jun 2023, 8:36 am
This is likely an underestimate for the specific drugs at the center of the FTC’s case, given that the Ho & Lee study focus on a drug class (statins) where generic competition exists and the number of branded options is quite large. [read post]
29 May 2014, 5:39 am
Levitt, an Associate General Counsel of Pfizer, Inc., and Janet Wittes, of the Statistics Collaborative, presented. [read post]
9 Jun 2023, 8:36 am
This is likely an underestimate for the specific drugs at the center of the FTC’s case, given that the Ho & Lee study focus on a drug class (statins) where generic competition exists and the number of branded options is quite large. [read post]
18 Jul 2014, 11:55 am
Pfizer, Inc., 716 F.3d 1087, 1092-93 (8th Cir. 2013). [read post]
17 May 2011, 6:31 pm
”); Pfizer, Inc. v. [read post]
17 Oct 2013, 5:00 am
Squibb & Sons, Inc. v. [read post]
9 Apr 2016, 11:01 am
Pfizer Inc. v. [read post]
9 Apr 2016, 11:01 am
Pfizer Inc. v. [read post]
5 May 2017, 11:24 am
See Apple Inc. v. [read post]
25 Aug 2017, 6:54 pm
” Pfizer, Inc. v. [read post]
